Latigo Biotherapeutics, Inc. · NASDAQ:LTGO

Deep Track Capital, LP reported a 7.03% stake in Latigo Biotherapeutics, Inc. (Schedule 13G)

Event Aug 7, 2026 · Filed Aug 13, 2026

Deep Track Capital, LP reported a 7.03% stake in Latigo Biotherapeutics, Inc., 4,446,656 shares, as a passive investor on Aug 7, 2026. Filed Aug 13, 2026 (Schedule 13G).

Stake
7.03%
Shares
4,446,656
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP7.03%4,446,656
Deep Track Biotechnology Master Fund, Ltd.7.03%4,446,656
David Kroin7.03%4,446,656

Source

View original at SEC

Related